Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
In contrast, patients prescribed this medication without a type 2 diabetes diagnosis are younger (average age of 47.5), more likely to be commercially insured (90.6%) and female (74.7%)
People with kidney disease should also consult their doctor before starting this treatment
Weight loss medication is designed to be taken consistently over time
A 17% Reduction in Overall Cancer Risk A landmark study published in JAMA Oncology (Dai H et al., August 2025), drawing on data from 14 health systems encompassing approximately 20 million patients, found that adults with obesity who were prescribed GLP-1 receptor agonists had a 17% lower risk of developing cancer compared to carefully matched non-users
Br J Pharmacol 171 , 723734, (2014)
US$ 20.51
US$ 23.28
US$ 27.72
US$ 20.89
